Gazzano-Santoro H, Parent J B, Conlon P J, Kasler H G, Tsai C M, Lill-Elghanian D A, Hollingsworth R I
Sepsis Research Department, XOMA Corporation, Berkeley, California 94710, USA.
Infect Immun. 1995 Jun;63(6):2201-5. doi: 10.1128/iai.63.6.2201-2205.1995.
Both human bactericidal/permeability-increasing protein (BPI) and a recombinant amino-terminal fragment of BPI (rBPI23) have been shown to bind with high affinity to the lipid A region of lipopolysaccharide (LPS) (H. Gazzano-Santoro, J. B. Parent, L. Grinna, A. Horwitz, T. Parsons, G. Theofan, P. Elsbach, J. Weiss, and P. J. Conlon, Infect. Immun. 60:4754-4761, 1992). In the present study, lipid A preparations derived from bacterial LPS as well as synthetic lipid A's and various lipid A analogs were used to determine the structural elements required for rBPI23 binding. rBPI23 bound in vitro to a variety of synthetic and natural lipid A preparations (both mono- and diphosphoryl forms), including lipid A's prepared from Escherichia coli and Salmonella, Neisseria, and Rhizobium species. Binding does not require that the origin of negative charge be phosphate, since rBPI23 bound with high affinity to lipid A's isolated from Rhizobium species that contain carboxylate (Rhizobium trifolii) or sulfate (Rhizobium meliloti) anionic groups and lack phosphate. Lipid A acyl chains are important, since rBPI23 did not bind to four synthetic variants of the beta(1-6)-linked D-glucosamine disaccharide lipid A head group, all devoid of acyl chains. rBPI23 also bound weakly to lipid X, a monosaccharide lipid precursor of LPS corresponding to the reducing half of lipid A. Lipid IVA, a precursor identical to E. coli lipid A except that it lacks the 2' and 3' acyl chains, was the simplest structure identified in this study that rBPI23 bound with high affinity. These results demonstrate that rBPI23 has a binding specificity for the lipid A region of LPS and binding involves both electrostatic and hydrophobic components.
人杀菌/通透性增加蛋白(BPI)和BPI的重组氨基末端片段(rBPI23)均已被证明能与脂多糖(LPS)的脂质A区域高亲和力结合(H. Gazzano-Santoro、J. B. Parent、L. Grinna、A. Horwitz、T. Parsons、G. Theofan、P. Elsbach、J. Weiss和P. J. Conlon,《感染与免疫》60:4754 - 4761,1992年)。在本研究中,使用了源自细菌LPS的脂质A制剂以及合成脂质A和各种脂质A类似物来确定rBPI23结合所需的结构元件。rBPI23在体外与多种合成和天然脂质A制剂(单磷酸和二磷酸形式)结合,包括从大肠杆菌、沙门氏菌、奈瑟氏菌和根瘤菌属制备的脂质A。结合并不要求负电荷的来源是磷酸盐,因为rBPI23与从含有羧酸盐(三叶草根瘤菌)或硫酸盐(苜蓿根瘤菌)阴离子基团且不含磷酸盐的根瘤菌属分离的脂质A高亲和力结合。脂质A酰基链很重要,因为rBPI23不与β(1 - 6)连接的D - 葡糖胺二糖脂质A头部基团的四种合成变体结合,这些变体均不含酰基链。rBPI23也与脂质X弱结合,脂质X是LPS的单糖脂质前体,对应于脂质A的还原半部分。脂质IVA是一种前体,与大肠杆菌脂质A相同,只是缺少2'和3'酰基链,是本研究中鉴定出的rBPI23能高亲和力结合的最简单结构。这些结果表明rBPI23对LPS的脂质A区域具有结合特异性,且结合涉及静电和疏水成分。